Royal Sense last traded at ₹75.00 (2026-10-13). Over the past month the stock moved -21.1%, three months the stock moved -42.5%, year the stock moved -69.8%. Its closing range over 52 weeks is ₹75.00 – ₹240.00, with the latest close 68.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2023, Royal Sense Ltd specializes in medical device and pharmaceutical trading.[1]
Business Overview:[1][2] RSL deals in Advanced medical devices, pharmaceuticals, diagnostics, and offers surgical solutions. It provides hospitals, laboratories, clinics, and institutions with products like surgical accessories, instruments, equipment, consumables, reagents, diagnostic kits, and disposable medical supplies
In the latest quarter (Mar 2026), Royal Sense reported sales of ₹60.00 crore (+445.5%) and net profit of ₹3.00 crore (-40.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 60.00 | 5.00 | 9.00 | 3.00 | 5.79 |
| Sep 2025 | 43.00 | 6.00 | 13.00 | 4.00 | 7.59 |
| Mar 2025 | 40.00 | 6.00 | 14.00 | 4.00 | 7.97 |
| Sep 2024 | 22.00 | 3.00 | 14.00 | 2.00 | 4.86 |
| Mar 2024 | 11.00 | 5.00 | 48.00 | 5.00 | 9.94 |
| Mar 2026 | |
|---|---|
| Sales growth | +445.5% |
| Operating profit growth | +0.0% |
| Net profit growth | -40.0% |
| EPS growth | -41.8% |
| OPM % | 9.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Royal Sense reported sales of ₹103.00 crore (+66.9%) and net profit of ₹7.00 crore (+10.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 103.00 | 11.00 | 11.00 | 7.00 | 13.36 |
| Mar 2025 | 61.73 | 8.88 | 14.39 | 6.33 | 12.74 |
| Mar 2024 | 17.80 | 2.26 | 12.70 | 1.59 | 3.24 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +246.8% | +66.9% |
| Operating profit growth | +292.9% | +23.9% |
| Net profit growth | +298.1% | +10.6% |
| EPS growth | +293.2% | +4.9% |
| OPM % | 14.4% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Royal Sense.
Get Free AI Stock Analysis FREE →No recent news available for Royal Sense.
Royal Sense shares were last quoted at ₹75.00 (-1.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Royal Sense has a price-to-earnings (P/E) ratio of 6.54 and a price-to-book (P/B) ratio of 1.23. The industry P/E is 45.63.
The 52-week high of Royal Sense is ₹260.00 and the 52-week low is ₹83.10.
The market capitalisation of Royal Sense is about ₹46.76 crore.
In the latest quarter (Mar 2026), Royal Sense reported sales of ₹60.00 crore (+445.5%) and net profit of ₹3.00 crore (-40.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Royal Sense has a 3-year ROE of 20.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 62.24% of Royal Sense.
Royal Sense belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z